Molecular Devices
Molecular Devices is one of Danaher’s Life Sciences companies. As an operating company, we encourage all associates to discover their potential and create devices that are “Helping Realize Life’s Potential”. For nearly 40 years, we have combine our individual strengths to collectively help address humanity’s most pressing challenges. We have partnered with scientists to help them achieve landmark discoveries and we are proud to say that with each discovery, we empower our associates to take pride in our products, service and culture. With our headquarters in San Jose, California, and offices around the world, we want each associate to be their authentic self. With over 1,100 associates spanning 21 countries, we’re embracing a culture that fosters diversity, equity, inclusion, and belonging.
At MolDev, we believe in winning together, inside and outside the office. We value the differences that bring us closer to each other, closer to the customers we serve, and closer to an improved quality of life everywhere. Our team members are as diverse as the customers they sere therefore for our business to thrive and succeed we believe that we must foster an environment that embraces authenticity and provides the necessary resources for their voices to be heard.
To support our associates and promote Diversity, Equity and Inclusion we are proud to have five different Associate Resource Groups, all women- led. These ARGs are open to all MolDev associates and we encourage all associates to join:
- Women + Friends
- Asian + Friends
- Black + Friends
- LatinX + Friends
- LGBTQ + Friends
Learn more here about how we are advancing diversity, taking action in our inclusion commitment and fostering equity amongst our associates at Molecular Devices and Danaher.
Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection.
From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics.
To learn more about how Molecular Devices helps fast-track scientific discovery, visit www.moleculardevices.com.
